SE428528B - Forfarande for framstellning av ett stabiliserat farmaceutiskt preparat innehallande en fysiologiskt aktiv prostaglandin av e-serien - Google Patents

Forfarande for framstellning av ett stabiliserat farmaceutiskt preparat innehallande en fysiologiskt aktiv prostaglandin av e-serien

Info

Publication number
SE428528B
SE428528B SE7503723A SE7503723A SE428528B SE 428528 B SE428528 B SE 428528B SE 7503723 A SE7503723 A SE 7503723A SE 7503723 A SE7503723 A SE 7503723A SE 428528 B SE428528 B SE 428528B
Authority
SE
Sweden
Prior art keywords
preparing
procedure
series
pharmaceutical preparation
physiologically active
Prior art date
Application number
SE7503723A
Other languages
English (en)
Swedish (sv)
Other versions
SE7503723L (sv
Inventor
D C Monkhouse
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7503723L publication Critical patent/SE7503723L/xx
Publication of SE428528B publication Critical patent/SE428528B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7503723A 1974-04-19 1975-04-01 Forfarande for framstellning av ett stabiliserat farmaceutiskt preparat innehallande en fysiologiskt aktiv prostaglandin av e-serien SE428528B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (2)

Publication Number Publication Date
SE7503723L SE7503723L (sv) 1975-10-20
SE428528B true SE428528B (sv) 1983-07-11

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7503723A SE428528B (sv) 1974-04-19 1975-04-01 Forfarande for framstellning av ett stabiliserat farmaceutiskt preparat innehallande en fysiologiskt aktiv prostaglandin av e-serien

Country Status (23)

Country Link
US (1) US3927197A (xx)
JP (1) JPS5337408B2 (xx)
AR (1) AR213271A1 (xx)
AT (1) AT348130B (xx)
AU (1) AU470631B2 (xx)
BE (1) BE828065A (xx)
BG (1) BG35326A3 (xx)
CA (1) CA1034044A (xx)
CS (1) CS191244B2 (xx)
DD (1) DD119131A5 (xx)
DE (1) DE2516105C3 (xx)
DK (1) DK138161B (xx)
ES (1) ES436613A1 (xx)
FI (1) FI62220C (xx)
FR (1) FR2267760B1 (xx)
GB (1) GB1474852A (xx)
HU (1) HU175405B (xx)
IE (1) IE40829B1 (xx)
IL (1) IL46994A (xx)
LU (1) LU72320A1 (xx)
NL (1) NL158384B (xx)
PH (1) PH11697A (xx)
SE (1) SE428528B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
PT725642E (pt) * 1993-10-27 2000-05-31 Upjohn Co Prostaglandina e 1 estabilizada
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
MX2020008680A (es) 2018-02-21 2020-09-25 Ai Therapeutics Inc Terapia de combinacion con apilimod y agentes glutamatergicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
IL46994A0 (en) 1975-06-25
FI751108A (xx) 1975-10-20
IE40829L (en) 1975-10-19
CA1034044A (en) 1978-07-04
US3927197A (en) 1975-12-16
DE2516105B2 (de) 1981-01-08
FR2267760B1 (xx) 1978-08-04
SE7503723L (sv) 1975-10-20
IL46994A (en) 1979-10-31
GB1474852A (en) 1977-05-25
FR2267760A1 (xx) 1975-11-14
AR213271A1 (es) 1979-01-15
NL7504274A (nl) 1975-10-21
IE40829B1 (en) 1979-08-29
FI62220B (fi) 1982-08-31
PH11697A (en) 1978-05-24
DD119131A5 (xx) 1976-04-12
AU7987775A (en) 1976-03-25
DE2516105A1 (de) 1975-10-23
DK138161C (xx) 1979-01-02
JPS5337408B2 (xx) 1978-10-09
BG35326A3 (en) 1984-03-15
HU175405B (hu) 1980-07-28
JPS50145515A (xx) 1975-11-21
AU470631B2 (en) 1976-03-25
LU72320A1 (xx) 1976-03-17
CS191244B2 (en) 1979-06-29
NL158384B (nl) 1978-11-15
DK138161B (da) 1978-07-24
BE828065A (fr) 1975-10-17
DK167075A (xx) 1975-10-20
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
ES436613A1 (es) 1977-04-16
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15

Similar Documents

Publication Publication Date Title
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
SE425941B (sv) Anvendning av vissa uretaner sasom fungicidiskt aktiv bestandsdel i ett fungicidiskt preparat
AR207355A1 (es) Un procedimiento para la preparacion de derivados del acido 7-(-(4-hidroxi-4-alquil-1-alquenil)ciclopentano)-1-heptanoico
SE437767B (sv) Forfarande for framstellning av ett antitumorlekemedel
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
SE428528B (sv) Forfarande for framstellning av ett stabiliserat farmaceutiskt preparat innehallande en fysiologiskt aktiv prostaglandin av e-serien
DK360875A (da) Fremgangsmade til fremstilling at et legemiddel i pelletform
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO143477C (no) Fremgangsmaate til fremstilling av et sinkholdig farmasoeytisk preparat.
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO143459C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive 2-fenylimino-imidazolidin-derivater
SE7504882L (sv) Forfarande for framstellning av ett nytt farmaceutiskt preparat.
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO144928C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater.
FI65370B (fi) Foerfarande foer framstaellning av ett fast farmaceutiskt preparat
SE7604373L (sv) Forfarande for framstellning av ett farmaceutiskt preparat innehallande biologiskt aktiva amider
SE419646B (sv) Forfarande for framstellning av 8-halogen-dibensofuran-3-ettiksyra-derivat
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO143317C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazindioksyder
NO137894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO143157C (no) Analogifremgangsmaate for fremstilling av antiinflammatorisk aktiv 2,3-dihydro-2-etylbenzofuran-5-yl-eddiksyre
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
SE434262B (sv) Forfarande for framstellning av farmaceutiskt godtagbara syraadditionssalter av n-butylaminderivat